KI16425 Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.
S-S?tze Betriebsanweisung:
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
Beschreibung
Lysophosphatidic acid (LPA) is a bioactive lipid mediator that signals through five distinct G protein-
coupled receptors (LPA
1-5). Ki16425 is a LPA receptor antagonist with selectivity for LPA
1 and LPA
3. It exhibits K
i values of 0.34, 6.5, and 0.93 μM for the human LPA
1, LPA
2, and LPA
3 receptors, respectively, as determined by measuring inositol phosphate production in RH7777-
transfected cells. Ki1642, at 10 μM, significantly blocks the response of a variety of cancer cell lines to LPA-
induced cell migration.
Verwenden
Ki16425 is a competitive, potent and reversible antagonist to LPA1, LPA2 and LPA3.
Biochem/physiol Actions
Ki 16425 possesses a short-lived inhibitory activity. It has been studied that Ki 16425 is effective in the inhibition of neuropathic pain‐like behaviors.
KI16425 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte